Aktiesnakken — Oktober 2010
-
jeg tror ikke GSk ønsker at købe genmab. De vil godt have dem i armslængde til at køre deres forskning. Men med arzerra´s succes også
-
på markedet hvorfor så ikke tage lidt flere stoffer ind. De vil jo så gerne oncology.
-
lidt friske rygter om Zealand pharma http://www.proinvestor.com/finansnyhed/10270606/Zealand-Pharma-paa-boersen-med-aktier-for-0,9-1-mia.-kr
-
GSK bliver kun køber af Genmab, hvis en ekstern byder på dem.
-
i know nothing... sagt helt uden ironi eller noget som helst.
-
-
iøvrigt en god dag for os aktionærer i Glaxo....dividenden 7% op
-
ja
-
....... GSK coming up -------
-
wassååå!?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind